ACHE and depressive symptom measurement: Prior research has reported that enhancing cholinergic signaling in the hippocampus—either through acetylcholinesterase deletion or through chemogenetic/optogenetic induction of acetylcholine release—elicits depression-like behaviors and increases stress susceptibility in mice [7, 8].